In Case You Missed It – Mr. Hartman Recaps the Company’s History and Plans for the Future
JACKSON CENTER, PA / ACCESSWIRE / March 29, 2018 / Premier Biomedical, Inc. (OTC PINK: BIEI) President and CEO, William A. Hartman was interviewed again by host, Donald Baillargeon on MoneyTV. In this segment, Mr. Hartman provided an update on the upcoming introduction of a new line of Sports Strength topical pain relief products.
Mr. Hartman believes that these new, stronger hemp oil based CBD topical pain relievers could help address the growing opioid crisis in America.
Premier’s pain relief products are available at select pharmacies and through their website, www.painreliefmeds.com.
You can view the entire video here:
Or copy and paste the following link into your browser. https://vimeo.com/261415694
For more information please contact:
About Premier Biomedical, Inc.
Premier Biomedical, Inc. (OTC PINK: BIEI) is a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases in humans. Premier has obtained, via exclusive license agreements, the technology behind three granted US Patents, multiple pending provisional patents. Founded in 2010, Premier has partnered with the University of Texas at El Paso (UTEP). In 2016, the company began developing a line of all-natural pain relief products which they began selling in early 2017 to address the rising opioid addiction problem. The company’s R&D efforts are centered in El Paso, TX, and their business offices are in Western Pennsylvania. The Company is a fully-reporting issuer whose common stock trades on the OTC marketplace maintained by OTC Markets Group, Inc. under the ticker symbol ”BIEI.” For more information please visit our website: http://www.premierbiomedical.com/.
Safe Harbor Notice
Certain statements contained herein are ”forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). Premier Biomedical, Inc. cautions that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. Premier Biomedical, Inc. undertakes no obligation to revise these statements following the date of this news release.
SOURCE: Premier Biomedical, Inc.